Target peptides for colorectal cancer therapy and diagnostics
US-10682399-B2 · Jun 16, 2020 · US
This page is not indexed by search engines while we improve data quality.
Cobbold Mark patents
Cobbold Mark is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cobbold Mark |
| Total patents | 11 |
| First publication | Jul 2, 2015 |
| Latest publication | Jun 16, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
US-2018066017-A1 · Mar 8, 2018 · US
Immunotherapeutic molecules and uses
US-9822180-B2 · Nov 21, 2017 · US
Target peptides for immunotherapy and diagnostics
US-9561266-B2 · Feb 7, 2017 · US
Re-directed immunotherapy
US-9402916-B2 · Aug 2, 2016 · US
Re-directed immunotherapy
US-9358282-B2 · Jun 7, 2016 · US
Target peptides for colorectal cancer therapy and diagnostics
US-2015328297-A1 · Nov 19, 2015 · US
Agents and Methods
US-2015297745-A1 · Oct 22, 2015 · US
Re-Directed Immunotherapy
US-2015250868-A1 · Sep 10, 2015 · US
Target peptides for immunotherapy and diagnostics
US-2015224182-A1 · Aug 13, 2015 · US
Recent patents
Latest publications not already listed above.
Immunotherapeutic molecules and uses
US-2015183875-A1 · Jul 2, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Birmingham | 12 |
| U Va Licensing & Ventures Group | 2 |
| Univ Virginia Patent Foundation | 2 |
| Univ Virginia Patent Found | 1 |
| Cobbold Mark | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.